Alyeska Investment Group, L.P. - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 31 filers reported holding ACHILLES THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$239,000
-20.6%
30,7300.0%0.00%0.0%
Q2 2021$301,000
-43.5%
30,730
-4.7%
0.00%
-57.1%
Q1 2021$533,00032,2300.01%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 5,014,687$49,094,0000.79%
Boxer Capital, LLC 1,536,016$15,038,0000.53%
Artal Group S.A. 2,255,375$22,080,0000.45%
Redmile Group, LLC 2,088,089$20,442,0000.30%
Affinity Asset Advisors, LLC 80,000$783,0000.28%
SPHERA FUNDS MANAGEMENT LTD. 292,194$2,861,0000.19%
Orbimed Advisors 1,584,845$15,516,0000.16%
Baker Brothers Advisors 2,591,366$25,369,0000.11%
Perceptive Advisors 1,510,750$14,790,0000.10%
Monashee Investment Management LLC 64,697$633,0000.08%
View complete list of ACHILLES THERAPEUTICS PLC shareholders